Mevalonic acid is limiting for N-linked glycosylation and translocation of the insulin-like growth factor-1 receptor to the cell surface. Evidence for a new link between 3-hydroxy-3-methylglutaryl-coenzyme a reductase and cell growth.
about
Statins for women with polycystic ovary syndrome not actively trying to conceiveStatins for women with polycystic ovary syndrome not actively trying to conceiveEnhancement of susceptibility to diverse skin tumor promoters by activation of the insulin-like growth factor-1 receptor in the epidermis of transgenic miceA mouse model for Zellweger syndromeEGFR-targeted therapy in malignant glioma: novel aspects and mechanisms of drug resistance.Congenital disorder of fucosylation type 2c (LADII) presenting with short stature and developmental delay with minimal adhesion defectStatins in the treatment of polycystic ovary syndrome.Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approachExposure to statins and risk of common cancers: a series of nested case-control studies.Relationship between the use of statins and patient survival in colorectal cancer: a systematic review and meta-analysis.Previous Exposure to Statin May Reduce the Risk of Subsequent Non-Hodgkin Lymphoma: A Nationwide Population-Based Case-Control StudyAdditive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling PathwaysLDL-lowering therapy and the risk of prostate cancer: a meta-analysis of 6 randomized controlled trials and 36 observational studies.Statins and the risk of gastric cancer in diabetes patients.Virtual screening of specific insulin-like growth factor 1 receptor (IGF1R) inhibitors from the National Cancer Institute (NCI) molecular databaseEvaluation of atorvastatin and simvastatin for treatment of multiple sclerosis.Concomitant Statin Use Has a Favorable Effect on Gemcitabine-Erlotinib Combination Chemotherapy for Advanced Pancreatic CancerAdditive interaction between the renin-angiotensin system and lipid metabolism for cancer in type 2 diabetes.HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons.Can statins reduce risk of lung cancer, especially among elderly people? A meta-analysis.The type 1 insulin-like growth factor receptor signalling system and targeted tyrosine kinase inhibition in cancer.Drug-subphenotype interactions for cancer in type 2 diabetes mellitus.Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor.The isoprenoid derivative N6 -benzyladenosine CM223 exerts antitumor effects in glioma patient-derived primary cells through the mevalonate pathway.Genetic basis for developmental toxicity due to statin intake using embryonic stem cell differentiation model.The interplay between cell signalling and the mevalonate pathway in cancer.In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells.Hypoxia induces peroxisome proliferator-activated receptor α (PPARα) and lipid metabolism peroxisomal enzymes in human glioblastoma cells.Statin use and mortality of patients with prostate cancer: a meta-analysis.Statins reduce dengue virus production via decreased virion assembly.Bioactive small molecules reveal antagonism between the integrated stress response and sterol-regulated gene expression.Expression of the insulin-like growth factor 1 receptor (IGF-1R) in breast cancer cells: evidence for a regulatory role of dolichyl phosphate in the transition from an intracellular to an extracellular IGF-1 pathway.Tyrosine kinase-dependent modulation of 3-hydroxy-3-methylglutaryl-CoA reductase in human breast adenocarcinoma SKBR-3 cellsActive isoprenoid pathway in the intra-erythrocytic stages of Plasmodium falciparum: presence of dolichols of 11 and 12 isoprene units.Simultaneous treatment with statins and aspirin reduces the risk of prostate cancer detection and tumorigenic properties in prostate cancer cell linesApposite insulin-like growth factor (IGF) receptor glycosylation is critical to the maintenance of vascular smooth muscle phenotype in the presence of factors promoting osteogenic differentiation and mineralization.Inhibition of the insulin-like growth factor-1 receptor enhances effects of simvastatin on prostate cancer cells in co-culture with bone.Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis-dependent mechanism.Simvastatin has deleterious effects on human first trimester placental explants.Downregulation of monocytic differentiation via modulation of CD147 by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
P2860
Q24234599-8FEB1035-EC06-40FC-A7D0-083895D3B161Q24236132-3C69E055-7430-44C1-B5A1-4D5CABDD11F1Q28377637-7912BE18-3135-46C5-9D15-294FFF639395Q28590797-3D720E93-BFF2-48B1-BDE1-2F05F47D6BF8Q30456087-B521B4F4-922C-4103-B29A-BD2668214FC1Q30577686-ED5033B9-F59E-472A-BC78-BD8B6950E208Q33789151-F8575A53-2ED2-4B43-8630-3D7E1A4A3913Q33925323-F43AF71C-1C5E-4949-86F5-FB18471F075AQ34028899-D64E2184-23FD-41E9-896E-99FE5FA6E986Q35648346-2D408767-541A-41B7-9D0A-95E2C5494D65Q35794786-6B4A25FD-3FF0-4E1E-8D98-10412D063F49Q35860831-901EED5E-2B7C-4A65-A99E-109EA45CBA2EQ35988999-153EAF88-8B68-40CA-A647-9D1E0FAE5DF0Q36521575-0828F69B-AD1F-4221-8449-6C1315B8BE16Q36538579-61B55EC9-14A1-4252-B28E-7390041F828EQ36817063-C5F4556B-31CF-4D19-8E12-95AC917BEAC6Q37124770-EB296D66-2633-419C-8E13-49CE2EF95E79Q37236318-E55EB3E1-D31D-49F1-9F25-7E038DFA091FQ37355991-15906A24-9D81-4BED-9D03-A0D8ED56EDF3Q37413636-DB22870D-2A63-45D7-A418-9D9C04AABD7BQ38097400-E4DB7AF6-2D98-4E7E-9960-ADBDB37AEB09Q38388443-3AE9F72E-40FB-4E46-B1F5-87BA79B4CB4EQ38733038-CDB3DF97-9CCF-436D-A4AD-4D458D55106BQ38832228-CCDB73C6-7E7C-4BC9-B8DF-F69367705035Q38906383-FFADA845-BE4E-4930-9057-AFB82A1654CEQ38937455-B16A495B-29F5-4D2F-B717-4EEB7AA6DA4DQ38968601-57B1F009-E4F0-4DED-A163-84C284B48F15Q39484769-F90C4E9E-FFBA-4A98-BA89-DB13A312B3BFQ39506823-21BA527F-26A2-488B-A135-40745A4D27ECQ39598018-A5CC5B6C-3B8B-4BE6-A215-024EB1EE224DQ40343371-21611AE3-16AB-43C0-8294-4B5CC2C58BD2Q40952840-116B6DCB-1920-41A5-9021-147D13E683FAQ41052623-0E72A9F3-86B6-40B6-9C2A-65AEA9FFBB5BQ42079385-0FDFB961-4ECE-4BF7-9370-F11F60FBC4DBQ42180829-CFF6D105-ED9C-4788-A01A-34F39F3A8492Q42728392-AEC50D4A-3A54-4632-A9A2-95445A747FB9Q42837186-185F8DEB-1E0C-4051-9FE0-C186B811BC4EQ44062588-B0BD4205-F044-4D29-9092-329A279E0096Q46548916-F4197A08-F989-4814-A19D-41719C1ACEE6Q47280518-4A73FD52-A2E4-4813-8883-59AF6F58C21B
P2860
Mevalonic acid is limiting for N-linked glycosylation and translocation of the insulin-like growth factor-1 receptor to the cell surface. Evidence for a new link between 3-hydroxy-3-methylglutaryl-coenzyme a reductase and cell growth.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Mevalonic acid is limiting for ...... e a reductase and cell growth.
@en
type
label
Mevalonic acid is limiting for ...... e a reductase and cell growth.
@en
prefLabel
Mevalonic acid is limiting for ...... e a reductase and cell growth.
@en
P2093
P2860
P356
P1476
Mevalonic acid is limiting for ...... e a reductase and cell growth.
@en
P2093
Hjertman M
P2860
P304
17453-17462
P356
10.1074/JBC.271.29.17453
P407
P577
1996-07-01T00:00:00Z